Company: WELNF
Filing Date: 2025-11-17
Form Type: DEF 14A
Source: 0001104659-25-113213
Chunk: 8

Company: Integrated Wellness Acquisition Corp
Filing Date: 2025-11-17
Form: DEF 14A
Chunk 8
---
ation Amendment Proposal, and the Redemption Limitation Amendment Proposal are not approved and the Business Combination
is not completed on or before December 15, 2025, we will be required to dissolve and liquidate our Trust Account by returning the
then-remaining funds in such account to the public shareholders.

Approval of the Extension
Amendment Proposal, the Liquidation Amendment Proposal and the Redemption Limitation Amendment Proposal will require the affirmative vote
of at least two-thirds of the votes cast by shareholders represented at the Meeting who, being entitled to do so, vote in person or by
proxy thereon. Approval of each of the Auditor Ratification Proposal and the Adjournment Proposal requires the affirmative vote of a simple
majority of the votes cast by the shareholders which are present themselves or represented by proxy at the Meeting who, being entitled
to do so, vote in person or by proxy thereon. The Adjournment Proposal will only be put forth for a vote if there are not sufficient votes
to approve the other proposals at the Meeting or if due to redemptions in connection with the M&A Amendment Proposals, the Company would not adhere to the continued listing requirements of the New York Stock Exchange, and in
such event, the Company will ask its shareholders to vote only upon the Adjournment Proposal and not on the Extension Amendment Proposal,
the Liquidation Amendment Proposal, the Redemption Limitation Amendment Proposal, or the Auditor Ratification Proposal.

The Board has fixed the close
of business on November 3, 2025 (the “Record Date”) as the date for determining the Company’s shareholders
entitled to receive notice of and vote at the Meeting and any adjournment thereof. Only holders of record of Ordinary Shares on that date
are entitled to have their votes counted at the Meeting or any adjournment thereof. However, the holders of Public Shares may elect to
redeem all or a portion of their shares in connection with the Meeting. On the Record Date, there were 4,060,481 Ordinary Shares issued
and outstanding.

The Board believes that given
the Company’s expenditure of time, effort and money on identifying a Business Combination, including the Btab Business Combination
or another Business Combination, circumstances warrant providing public shareholders an opportunity to consider the Business Combination.

After careful consideration of all relevant factors, the Board has determined that each of the proposals is advisable and recommends that you vote or give instruction to vote “FOR” each proposal.

Enclosed is the proxy statement
containing detailed information concerning